YARW (Yarrow Bioscience) Total Operating Expense: $7.06 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YARW Yarrow Bioscience Inc YARW
13 GF Score
Price $26.22
View Full Analysis

What is Yarrow Bioscience Total Operating Expense?

Yarrow Bioscience YARW -2.78% 13 Total Operating Expense is $7.06 Mil as of Jun. 2026. GuruFocus rates YARW with a GF Score™ of 13/100.

Yarrow Bioscience's Total Operating Expense for the three months ended in Jun. 2026 was $3.20 Mil. Yarrow Bioscience's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was $7.06 Mil.

Yarrow Bioscience Total Operating Expense Related Terms

Yarrow Bioscience Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Yarrow Bioscience's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yarrow Bioscience Total Operating Expense Chart

Yarrow Bioscience Annual Data
Trend Dec25
Total Operating Expense
0.00

Yarrow Bioscience Quarterly Data
Jun25 Dec25 Mar26 Jun26
Total Operating Expense 7.61 0.99 2.86 3.20
YARW
13GF Score
Yarrow Bioscience Inc YARW
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yarrow Bioscience Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $7.06 Mil mean?
Yarrow Bioscience (YARW) has a Total Operating Expense of $7.06 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Yarrow Bioscience and its competitors.
Is Yarrow Bioscience's Total Operating Expense too high?
Yarrow Bioscience's current Total Operating Expense is $7.06 Mil. Overall, Yarrow Bioscience has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's Total Operating Expense compare to CGTX and RANI?
Yarrow Bioscience's Total Operating Expense of $7.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Yarrow Bioscience and its competitors. Yarrow Bioscience's current Total Operating Expense is $7.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current Total Operating Expense of $7.06 Mil. The current Total Operating Expense is $7.06 Mil. Yarrow Bioscience's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current Total Operating Expense is $7.06 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yarrow Bioscience Business Description

Address 251 Little Falls Drive, County of New Castle, City of Wilmington, DE, USA, 19808
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
13GF Score

Get the complete analysis for YARW

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.22
Price